IL6R and Miyoshi myopathy: Conversely, sgp130 acts as a decoy receptor to prevent binding of the IL-6/IL-6R complex to membrane CD130, thereby inhibiting downstream STAT3 signaling and MM cell proliferation (Fig. 7) [21].